G protein-linked receptors: Pharmacological evidence for the formation of heterodimers

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 251-257

  Maggio, Roberto ^a   Barbier, Pascaline ^a   Colelli, Antonella ^a   Salvadori, Federica ^a   Demontis, Graziella ^b   Corsini, Giovanni U ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; ASPARAGINE; GUANINE NUCLEOTIDE BINDING PROTEIN; METHYLSCOPOLAMINE; MUSCARINIC M3 RECEPTOR; PIRENZEPINE; SERINE; TRIPITRAMINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; RECEPTOR BINDING;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DIMERIZATION; GTP-BINDING PROTEINS; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, MUSCARINIC; RECOMBINANT FUSION PROTEINS;

EID: 0032822381     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bai M, Trivedi S and Brown EM (1998) Dimerization of extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 273:23605-23610.
2. Bai M, Trivedi S, Kifor O, Quinn SJ and Brown EM (1999) Intermolecular interacting between dimeric calcium-sensing receptor monomers are important for its normal function. Cell Biol 96:2834-2839.
3. Barbier P, Colelli A, Bolognesi ML, Minarini A, Tumiatti V, Corsini GU, Melchiorre C and Maggio R (1998) Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor. Eur J Pharmacol 355:267-274.
4. Barbier P, Maggio R, Colelli A, Vaglini F, Fornai F and Corsini GU (1996) Reconstitution of functional dopamine receptors by coexpression of N- and C-terminal receptor domains (Abstract). Society for Neurocience 26th Annual Meeting, p 825, Washington, DC.
5. Blüml K, Mutschler E and Wess J (1994) Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J Biol Chem 269:18870-18876.
6. Bonner TI, Buckley NJ, Young AC and Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science (Wash DC) 237:527-532.
7. Bonner TI, Young AC, Brann MR and Buckley NJ (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1:403-410.
8. Ciruela F, Casado V, Mallol J, Canela EI, Lluis C and Franco R (1995) Immunological identification of A(1) adenosine receptors in brain cortex. J Neurosci Res 42:818-828.
9. i) and the concentration of per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
10. Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
11. Cvejic S and Devi LA (1997) Dimerization of δ opioid receptor. J Biol Chem 272:26959-26964.
12. Eglen RM, Reddy H, Watson N and Challiss RAJ (1994) Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci 15:114-119.
13. Fukamauchi F, Saunders PL, Hough C and Chuang DM (1993) Agonist-induced down-regulation and antagonist-induced up-regulabion of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol Pharmacol 44:940-949.
14. Gouldson PR, Snell CR, Bywater RP, Higgs C and Reynolds CA (1998) Domain swapping in G-protein coupled receptor dimers. Protein Eng 11:1181-1193.
15. 2-adrenergic receptor which exploits the domain structure of G-protein coupled receptors. J Med Chem 40:3871-3886.
16. BR2. Nature (Lond) 396:674-679.
17. 2AR through receptor dimerization. Biochem J 330:287-293.
18. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
19. Huang RRC, Vicario PP, Strader CD, Fong TM (1995) Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry 34:10048-10055.
20. Huang RRC, Yu H, Strader CD and Fong TM (1994) Interaction of substance-P with the 2nd and 7th transmembrane domains of neurokinin-1 receptor. Biochemistry 33:3007-3013.
21. Hulme EC, Birdsall NJM and Buckley NJ (1990) Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673.
22. Kahn TW and Engelman DM (1992) Bacteriorhodopsin can be refolded from two independently stable transmembrane helices and the complementary five-helix fragment. Biochemistry 31:6144-6151.
23. B-receptor subtypes assemble into functional heteromeric complexes. Nature (Lond) 396:683-687.
24. 2-adrenergic receptors: Delineation of domains involved in effector coupling and ligand binding specificity. Science (Wash DC) 240:1310-1316.
25. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A, Kangawa K, Kojima K, Matsuo H, Hirose T and Numa S (1986) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (Lond) 323:411-416.
26. Maggio R, Barbier P, Bolognesi ML, Minarini A, Tedeschi D and Melchiorre C (1994) Binding profile of selective muscarinic receptor antagonist tripitramine. Eur J Pharmacol 268:459-462.
27. Maggio R, Barbier P, Fornai F and Corsini GU (1996) Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J Biol Chem 49:31055-31060.
28. Maggio R, Vogel Z and Wess J (1993a) Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett 319:195-200.
29. Maggio R, Vogel Z and Wess J (1993b) Coexpression studies with mutant muscarinic/ adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein linked receptors. Proc Natl Acad Sci USA 90:3103-3107.
30. Monnot C, Bihoreau C, Conchon S, Curnow KM, Corvol P and Clauser E (1996) Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling - reconstitution of the binding site by coexpression of two deficient mutants. J Biol Chem 271:1507-1513.
31. Ng GYK, O'Dowd BF, Lee SP, Chung HT, Brann MR, Seeman P and George SR (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227:200-204.
32. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J and Capon, DJ (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 6:3923-3929.
33. Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE and Zhang R (1991) Evidence for paired M2 musccarinic receptors. Mol Pharmacol 39:211-221.
34. Ridge KD, Lee SSJ and Yao LL (1995) In vivo assembly of rhodopsin from expressed polypeptide fragments. ProcC Natl Acad Sci USA 92:3204-3208.
35. Romano C, Yang WL and O'Malley KL (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem 271:28612-28616.
36. Schöneberg T, Liu J and Wess J (1995) Plasma membrane localization and functional rescue of truncated forms of G protein-coupled receptor. J Biol Chem 270:18000-18006.
37. Schöneberg T, Yun J, Wenkert D and Wess J (1996) Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 15:1283-1291.
38. Weiner DM, Levey AI and Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-7054.
39. B receptor. Nature (Lond) 396:679-682.
40. Wreggett KA and Wells JW (1995) Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem 270:22488-22499.